RA Capital Management, L.P. 13D and 13G filings for Vor Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-30 6:51 pm Purchase |
2024-12-26 | 13D | Vor Biopharma Inc. VOR |
RA Capital Management, L.P. | 39,709,850 31.900% |
16,929,507 (+74.32%) |
Filing |
| 2023-08-11 5:05 pm Purchase |
2023-08-10 | 13D | Vor Biopharma Inc. VOR |
RA Capital Management, L.P. | 22,780,343 33.700% |
20,198 (+0.09%) |
Filing |
| 2022-12-09 4:31 pm Purchase |
2022-12-07 | 13D | Vor Biopharma Inc. VOR |
RA Capital Management, L.P. | 22,760,145 34.800% |
11,628,845 (+104.47%) |
Filing |
| 2022-11-14 4:46 pm Purchase |
2022-11-10 | 13D | Vor Biopharma Inc. VOR |
RA Capital Management, L.P. | 11,131,300 28.780% |
10,327 (+0.09%) |
Filing |
| 2021-02-19 4:30 pm Purchase |
2021-02-09 | 13D | Vor Biopharma Inc. VOR |
RA Capital Management, L.P. | 11,120,973 30.000% |
11,120,973 (New Position) |
Filing |